St. Jude possibly most bruised by Medtronic ICD lead recall

November 2007
Medical Technology & Devices Week;11/19/2007, Vol. 5 Issue 46, p4
The article talks about the impact of Medtronic's recall of its Sprint Fidelis leads on medical device firm St. Jude. Medtronic pulled its Fidelis family of implantable cardioverter defibrillation (ICD) leads in October 2007 because they may break inside the body. This recall not only affected the ICD market but St. Jude's Riata leads have come under heavy scrutiny as rumors rapidly began to surface about the devices being next in line for a recall.


Related Articles

  • Recalled ICD Leads. DiMarco, John P. // Clinical Cardiology Alert;Jul2008, Vol. 27 Issue 7, p55 

    The article discusses research on the outcome of an advisory released by Medtronic Inc. recalling its Fidelis implantable cardioverter-defibrillators (ICD). It references a study by A. D. Krahn and colleagues published in a 2008 issue of "Heart Rhythm." A total of 21 out of 23 adult ICD implant...

  • Study delivers inconclusive data on test from Cambridge Heart.  // Medical Device Daily;11/8/2007, Vol. 11 Issue 215, p4 

    The article discusses the results of the MASTER I trial sponsored by Cambridge Heart and Medtronic, which investigated a diagnostic test aimed to identify patients who should receive heart defibrillators. According to Cambridge Heart, its test can allow doctors predict which patients with...

  • Physicians want transparency as Guidant lawsuits grow. Eggertson, Laura // CMAJ: Canadian Medical Association Journal;10/11/2005, Vol. 173 Issue 8, p855 

    Reports on the call of Canadian physicians who implant cardiac defibrillators on Guidant Corporation and other manufacturers to notify doctors and patients as soon as device failures occur. Recall of several pacemaker models by Guidant; Rationale of Guidant for not notifying patients or...

  • Medtronic withdraws some heparin - coated products.  // Medical Technology & Devices Week;5/12/2008, Vol. 6 Issue 19, p5 

    This article reports on the decision of Medtronic to pull out from the market some of its disposable heart surgery products because of concerns about a coating of contaminated heparin. It called its move an a voluntary and precautionary recall. The Carmeda BioActive surface used during...

  • Contaminated heparin results in product recall by Medtronic. Pedersen, Amanda // Cardiovascular Devices & Drugs;May2008, Vol. 14 Issue 5, p28 

    The article reports on the recall of some disposable heart surgery products by Medtronic because of concerns about a coating of contaminated heparin. Disposable products with the Carmeda BioActive surface that are used during cardiopulmonary bypass (CPB) for heart surgeries were included in the...

  • AED Available Without Prescription. Zipes, Douglas // Medical Update;2004, Vol. 30 Issue 4, p3 

    Reports on the clearance issued to the Philips HeartStart Home Defibrillator for over-the-counter sales in the U.S. Importance of automated external defibrillators (AED) to patients with heart disease; Benefits of removing the prescription requirement for AED; Function of AED; Percentage of...

  • Survival Rates of Cardiac Arrest Patients Improve With Defibrillation, Aggressive Treatment, Says Mayo Clinic Proceedings Study.  // Ascribe Newswire: Medicine;5/13/2004, p88 

    The long-term survival rate of patients who suffer cardiac arrest away from a hospital is much better when they are revived with a defibrillator and are entered into an aggressive treatment program while hospitalized, according to a journal "Mayo Clinic Proceedings" study led by researcher T....

  • Biventricular pacing for heart failure. Lane, Rebecca E; Mayet, Jamil; Peters, Nicholas S // BMJ: British Medical Journal (International Edition);5/3/2003, Vol. 326 Issue 7396, p944 

    Discusses the development of biventricular pacing in an attempt to restore synchronous ventricular contraction and improve left ventricular function. Biventricular pacing that involves the transvenous placement of a third pacing lead via the right atrium and coronary sinus into a left...

  • Medtronic Q1 results show challenges in ICDs/spine. PEDERSEN, AMANDA // Medical Device Daily;8/24/2011, Vol. 15 Issue 161, p1 

    The article reports on the financial results of Medtronic of Minneapolis, Minnesota for its first quarter of fiscal year 2012 ending on July 29, 2011, which showed that implantable cardioverter defibrillators and spinal products are its trouble areas. According to chief executive and chairman...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics